Loading chat...

PA HR17

Resolution

Status

Introduced

1/23/2017

Primary Sponsor

Frank Burns

Click for details

Origin

House of Representatives

2017-2018 Regular Session

AI Summary

Legislative Description

Requesting the Congress of the United States to urge the Food and Drug Administration to reverse its directive allowing OxyContin to be prescribed to children 11 to 16 years of age.

Last Action

Removed from table

9/13/2018

Committee Referrals

Human Services1/25/2017

Full Bill Text

No bill text available